2017 Annual Meeting | N8 - Neuroscience in the Clinic: Novel Therapeutic Targets in Critical Care Neurology: Intracerebral and Intraventricular Hemorrhage

Date Thursday 04/27/17

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) David Y. Hwang, MD, FAAN, Sherry Hsiang-Yi Chou, MD

Topic(s) Neuro Trauma, Critical Care, and Sports Neurology

Learning Objectives Participants should become familiar with the most recent clinical trials related to intracerebral and intraventricular hemorrhage management, including when intraventricular tPA may be indicated for patients with intraventricular hemorrhage.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Interactive, Audience Participation

Event Timeline
03:30 PM - 03:40 PM	Speaker	Welcome and Case Presentation Sherry Hsiang-Yi Chou, MD, David Y. Hwang, MD, FAAN
03:30 PM - 05:30 PM	Abstract	001 - Association between Leukocyte Count and Perihematomal Edema Growth After Primary Intracerebral Hemorrhage Aaron M. Gusdon, MD
03:30 PM - 05:30 PM	Abstract	002 - Role Of Sulfonylureas In Perihematomal Edema In Spontaneous Intracerebral Hemorrhage Shailesh Male, MD
03:40 PM - 04:00 PM	Speaker	Intraventricular Hemorrhage: the History of Intraventricular tPA Use and the CLEAR III Trial Results Daniel F. Hanley, MD, FAAN
04:00 PM - 04:15 PM	Speaker	After CLEAR III: When Might One Consider Using Intraventricular tPA? Alejandro A. Rabinstein, MD, FAAN
04:15 PM - 04:30 PM	Speaker	The Future of Clinical Research in Intraventricular Hemorrhage Management Wendy C. Ziai, MD
04:30 PM - 04:45 PM	Speaker	N8.001: Association between Leukocyte Count and Perihematomal Edema Growth After Primary Intracerebral Hemorrhage Aaron M. Gusdon, MD
04:45 PM - 05:00 PM	Speaker	N8.002: Role Of Sulfonylureas In Perihematomal Edema In Spontaneous Intracerebral Hemorrhage Shailesh Male, MD
05:00 PM - 05:30 PM	Q&A	Panel Discussion

Faculty Disclosures
Wendy C. Ziai, MD	Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lumosa. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bard. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ziai has received research support from NIH. Dr. Ziai has received publishing royalties from a publication relating to health care. Dr. Ziai has received personal compensation in the range of $500-$4,999 for serving as a Consultant with DOJ.
Alejandro A. Rabinstein, MD, FAAN	Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
David Y. Hwang, MD, FAAN	The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. Dr. Hwang has received publishing royalties from a publication relating to health care. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Associate Medical Director with New England Donor Services.
Sherry Hsiang-Yi Chou, MD	Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL-Behring. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL-Behring. The institution of Dr. Chou has received research support from NIH/NINDS. The institution of Dr. Chou has received research support from University of Pittsburgh.
Daniel F. Hanley, MD, FAAN	Dr. Hanley has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurotrope. Dr. Hanley has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. The institution of Dr. Hanley has received research support from NIH/NCATS. The institution of Dr. Hanley has received research support from NIH/NINDS.
Shailesh Male, MD	Dr. Male has nothing to disclose.
Aaron M. Gusdon, MD	The institution of Dr. Gusdon has received research support from NINDS.
Rwoof A. Reshi, MD	Dr. Reshi has nothing to disclose.
Jetter T. Robertson, MD	Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Preferred One . Dr. Robertson has stock in Doximity.
Babak Navi, MD	Dr. Navi has nothing to disclose.
Christopher Streib, MD	Dr. Streib has nothing to disclose.
	No disclosure on file
Alexander Merkler, MD	Dr. Merkler has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurohospitalist. Dr. Merkler has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for n/a.
Mohammed H. Alkuwaiti, MD	No disclosure on file
Caitlin Bell	No disclosure on file
Santosh B. Murthy, MD	Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Mustapha A. Ezzeddine, MD, FAAN	The institution of Dr. Ezzeddine has received research support from NIH.
Hooman Kamel, MD	Dr. Kamel has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Kamel has received personal compensation in the range of $50,000-$99,999 for serving as a Endpoint adjudication committee with Boehringer-Ingelheim.
Costantino Iadecola, MD	Dr. Iadecola has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Broadview Ventures.

��ɫ��

��ɫ��